Latest Restenosis Stories
MAJESTIC Trial Meets Performance Endpoint With Compelling Results MARLBOROUGH, Mass., April 28, 2015 /PRNewswire/ -- In an important clinical advancement in the treatment of peripheral artery
Heart Fit Clinic introduces External Counterpulsation, a safe, evidence-based, and non-surgical heart disease treatment for the people of Calgary. Calgary, AB
According to a new report by iData Research, the initial adoption rate of drug-eluting stents in the U.S.
According to a new report by iData Research, despite the progress in bare metal stent design, in-stent restenosis remains high.
The advancements within drug-coated balloons have the potential to alter the entire market for peripheral vascular devices by replacing stents for certain procedures, reports iData Research.
CGuardTM All Comer Data Continues to Show Excellent Clinical Benefits of the MicroNetTM Covered Technology BOSTON, Jan.
LONDON, Nov. 11, 2014 /PRNewswire/ -- REPORT DESCRIPTIONGlobal Market Watch:Global Coronary Stents sector is projected to reach US$9.5 billion by 2016.